Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Polaryx Therapeutics, Inc. (PLYX) had Weighted-Average Shares Outstanding (Diluted) of 45.42M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-8.98M |
|
-- |
|
-- |
|
$7.82M |
|
$-7.82M |
|
$-1.16M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-8.98M |
|
$-7.82M |
|
$-7.82M |
|
45.42M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
45.42M |
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$5.17M |
|
-- |
|
-- |
|
$5.17M |
|
$0.60M |
|
-- |
|
-- |
|
$0.60M |
|
$4.57M |
|
$4.57M |
|
$4.57M |
|
47.34M |
|
| Cash Flow Statement Financials | |
$-3.94M |
|
-- |
|
$4.47M |
|
$4.62M |
|
$5.14M |
|
$0.52M |
|
$4.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-196.82% |
|
-196.82% |
|
-173.79% |
|
-196.82% |
|
$0.10 |
|
$-0.09 |
|
$-0.09 |
|